• Something wrong with this record ?

Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity

L. Petruzelkova, K. Pickova, Z. Sumnik, J. Soupal, B. Obermannova,

. 2017 ; 19 (5) : 299-304.

Language English Country United States

Document type Comparative Study, Journal Article, Observational Study

BACKGROUND: The prevention of postexercise nocturnal hypoglycemia after prolonged physical activity using sensor-augmented pump (SAP) therapy with predictive low-glucose management (PLGM) has not been well studied. We conducted a study at a pediatric diabetes camp to determine whether a SAP with PLGM reduces the frequency of nocturnal hypoglycemia after prolonged physical activity more effectively than a SAP with a carbohydrate intake algorithm. METHODS: During a 1-week sport camp, 20 children (aged 10-13 years) with type 1 diabetes (T1D) managed by SAP therapy either with (n = 7) or without PLGM (n = 13) were studied. The hypoglycemia management strategy and the continuous glucose monitoring (CGM)/PLGM settings were standardized. The incidence, severity, and duration of hypoglycemia and carbohydrate intake were documented and compared. RESULTS: The PLGM system was activated on 78% of all nights (once per night on average). No difference was found between the SAP and PLGM groups in the mean overnight glucose curve or mean morning glucose (7.8 ± 2 mmol/L vs. 7.4 ± 3 mmol/L). There was no difference in the frequency and severity of hypoglycemia. However, the SAP group consumed significantly more carbohydrates to prevent and treat hypoglycemia than those in the PLGM group; the values were 10 ± 2 and 1 ± 2 gS (P < 0.0001) in the SAP and PLGM groups, respectively. Moreover, the SAP group spent a significantly longer time in hypoglycemia (64 ± 2 min vs. 38 ± 2 min, P < 0.05). We observed a difference in the time distribution of nocturnal hypoglycemia (10 to 12 p.m. in the PLGM group and 3 to 7 a.m. in the SAP group, P < 0.05). CONCLUSION: With PLGM system, euglycemia after prolonged physical activity was largely maintained with a minimal carbohydrate intake.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010554
003      
CZ-PrNML
005      
20180419085954.0
007      
ta
008      
180404s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/dia.2016.0459 $2 doi
035    __
$a (PubMed)28520532
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Petruzelkova, Lenka $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
245    10
$a Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity / $c L. Petruzelkova, K. Pickova, Z. Sumnik, J. Soupal, B. Obermannova,
520    9_
$a BACKGROUND: The prevention of postexercise nocturnal hypoglycemia after prolonged physical activity using sensor-augmented pump (SAP) therapy with predictive low-glucose management (PLGM) has not been well studied. We conducted a study at a pediatric diabetes camp to determine whether a SAP with PLGM reduces the frequency of nocturnal hypoglycemia after prolonged physical activity more effectively than a SAP with a carbohydrate intake algorithm. METHODS: During a 1-week sport camp, 20 children (aged 10-13 years) with type 1 diabetes (T1D) managed by SAP therapy either with (n = 7) or without PLGM (n = 13) were studied. The hypoglycemia management strategy and the continuous glucose monitoring (CGM)/PLGM settings were standardized. The incidence, severity, and duration of hypoglycemia and carbohydrate intake were documented and compared. RESULTS: The PLGM system was activated on 78% of all nights (once per night on average). No difference was found between the SAP and PLGM groups in the mean overnight glucose curve or mean morning glucose (7.8 ± 2 mmol/L vs. 7.4 ± 3 mmol/L). There was no difference in the frequency and severity of hypoglycemia. However, the SAP group consumed significantly more carbohydrates to prevent and treat hypoglycemia than those in the PLGM group; the values were 10 ± 2 and 1 ± 2 gS (P < 0.0001) in the SAP and PLGM groups, respectively. Moreover, the SAP group spent a significantly longer time in hypoglycemia (64 ± 2 min vs. 38 ± 2 min, P < 0.05). We observed a difference in the time distribution of nocturnal hypoglycemia (10 to 12 p.m. in the PLGM group and 3 to 7 a.m. in the SAP group, P < 0.05). CONCLUSION: With PLGM system, euglycemia after prolonged physical activity was largely maintained with a minimal carbohydrate intake.
650    _2
$a činnosti denního života $7 D000203
650    _2
$a mladiství $7 D000293
650    _2
$a algoritmy $7 D000465
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a dítě $7 D002648
650    12
$a chování dětí $7 D002652
650    _2
$a kombinovaná terapie $x škodlivé účinky $7 D003131
650    _2
$a Česká republika $x epidemiologie $7 D018153
650    _2
$a diabetes mellitus 1. typu $x krev $x dietoterapie $x farmakoterapie $x metabolismus $7 D003922
650    _2
$a diabetická dieta $x škodlivé účinky $7 D003927
650    _2
$a dietní sacharidy $x škodlivé účinky $x metabolismus $7 D004040
650    12
$a cvičení $7 D015444
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hyperglykemie $x prevence a kontrola $7 D006943
650    _2
$a hypoglykemie $x epidemiologie $x etiologie $x prevence a kontrola $7 D007003
650    _2
$a incidence $7 D015994
650    12
$a inzulinové infuzní systémy $x škodlivé účinky $7 D007332
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a testování materiálů $7 D008422
650    12
$a ambulantní monitorování $x škodlivé účinky $7 D018670
650    12
$a sporty $7 D013177
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Pickova, Klara $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
700    1_
$a Sumnik, Zdenek $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
700    1_
$a Soupal, Jan $u 2 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague , Czech Republic .
700    1_
$a Obermannova, Barbora $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
773    0_
$w MED00173679 $t Diabetes technology & therapeutics $x 1557-8593 $g Roč. 19, č. 5 (2017), s. 299-304
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28520532 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180419090055 $b ABA008
999    __
$a ok $b bmc $g 1288039 $s 1007366
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 19 $c 5 $d 299-304 $i 1557-8593 $m Diabetes technology & therapeutics $n Diabetes Technol Ther $x MED00173679
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...